Abstract
This study details the development of a dissolving microneedle (DMN) patch loaded with Atractylodes macrocephala Rhizoma (AM) aqueous extract for the treatment of mammary gland hyperplasia (MGH). By utilizing a Box-Behnken Design (BBD) for formulation optimization, researchers created a transdermal delivery system with superior mechanical strength and skin penetrability. In vivo results demonstrate that AM-DMN treatment effectively regulates systemic hormone levels and restores gut microbiota diversity, providing evidence for a therapeutic "gut-mammary axis."
Introduction
Mammary gland hyperplasia (MGH) is a prevalent non-inflammatory proliferative disorder characterized by breast lumps and pain, primarily driven by endocrine imbalances. While Western medical interventions often involve hormone inhibitors or surgical procedures—both associated with significant side effects—Traditional Chinese Medicine (TCM) offers a holistic alternative. However, the oral administration of TCM extracts is frequently hindered by poor bioavailability due to the hepatic first-pass effect and gastrointestinal degradation.
To overcome these barriers, this research explores the use of dissolving microneedles (DMNs). These micron-scale needles bypass the stratum corneum to deliver therapeutic agents directly into the dermis. This approach offers a painless, self-administered, and highly bioavailable alternative to traditional oral or injectable routes.
Methodology
Microneedle Fabrication and Optimization
The researchers employed a micromolding technique to create DMNs using a blend of biocompatible polymers: Polyvinyl alcohol (PVA), Hyaluronic acid (HA), and Polyvinylpyrrolidone (PVPK30). To determine the ideal ratio for maximum skin penetration, a Box-Behnken Design (BBD)—a response surface methodology—was utilized to mathematically optimize polymer concentrations.
Characterization and In Vivo Modeling
The physical properties of the DMNs were assessed via electron microscopy for morphology, compression tests for mechanical toughness, and Parafilm® layer penetration to simulate skin entry. For pharmacological evaluation, an MGH rat model was induced using estradiol benzoate and progesterone. The therapeutic efficacy of AM-DMN patches was then measured against serum hormone levels and intestinal health.
Microbiome Analysis
To investigate systemic impacts, the team conducted 16S rRNA high-throughput sequencing on intestinal contents. This allowed for the mapping of changes in the gut bacterial community, identifying Operational Taxonomic Units (OTUs) and diversity indices (Chao1 and Shannon) across control, model, and treatment groups.
Results
Formulation Optimization
The mathematical optimization identified the ideal DMN formulation as 6.0% PVA, 15.5% HA, and 16.0% PVPK30. This specific combination achieved a penetration rate of over 96% through four layers of Parafilm, ensuring effective drug delivery into the dermis. The optimized needles achieved a rapid drug release of 64.96% within 30 minutes.
Hormonal and Microbiome Restoration
Treatment with AM-DMNs significantly modulated the endocrine environment in MGH rats. Serum levels of Estradiol (E2) and Prolactin (PRL) were reduced, while Progesterone (P) levels increased, effectively reversing the disease-induced hormonal imbalance.
Furthermore, the study revealed a profound impact on the gut microbiome:
- Diversity Recovery: The MGH model group showed a sharp decline in OTUs (from 1318 to 492), which was largely restored to 982 following AM-DMN treatment.
- Taxonomic Shifts: The treatment specifically increased the abundance of beneficial genera such as Allobaculum and Clostridiales, which are associated with healthy metabolic and endocrine regulation.
Discussion
The most significant insight from this research is the confirmation of a "gut-mammary axis." The study bridges ancient TCM "Spleen and Stomach" theory—which links digestive health to systemic wellness—with modern bioengineering. The results suggest that AM extract does not merely treat breast tissue locally; it repairs the systemic endocrine environment, which subsequently stabilizes the gut microbiome.
Conclusion
The prepared AM-loaded microneedles demonstrate excellent toughness and the ability to effectively deliver herbal extracts to treat MGH. While the specific molecular pathways by which AM extract regulates intestinal flora remain to be fully mapped, this study provides a robust foundation for using transdermal TCM delivery to treat proliferative diseases through systemic and microbiome modulation. Future work will focus on long-term biocompatibility and identifying the specific active compounds within the AM extract responsible for these therapeutic effects.
Summary updated